Biostatistics 3 articles

biostatistics refers to an application of statistical theory and methods to biomedical and health data within clinical development and regulated biomedical research. The concept is grounded in statistical methods for biomedical research and clinical trial statistics, with survival analysis providing the next layer needed to understand its practical behavior in research or therapy. Biostatistics supplies the quantitative design and inference framework for biomedical research; it is distinct from clinical data collection, trial operations and pharmacovigilance.

Biotechnology News & Analysis

September 22, 2026, 1:22 AM · 3 mins read

Phase III trial data volumes double every seven years as complexity becomes the new normal

Phase III clinical trials now generate 5.9 million data points per protocol on average, with data volumes rising 11 percent annually since 2020 and operational models straining to keep pace.

AI in Biology

September 21, 2026, 7:20 AM · 5 mins read

AI patient profiling challenges the meaning of failed clinical trials

A failed Phase 3 trial does not always mean a drug is ineffective. Luca Pani of NetraMark argues that AI-driven patient selection could transform how clinical evidence is generated and interpreted.

Bioinformatics Methods & Tools

September 18, 2026, 11:15 PM · 3 mins read

Certara tackles clinical data headaches with early standards checks

Certara is betting that catching data standard problems at the source can save clinical trial sponsors months of costly remediation and regulatory headaches.